Asset
BRODALUMAB
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01199289 | phase2 | completed | 2010-10-04 | 2011-12-21 | Amgen | A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma |
| NCT01059448 | phase2 | terminated | 2010-06-03 | 2011-04-05 | Amgen | Safety and Efficacy of AMG 827 in Subjects With RA |
FDA applications (0)
This company has no applications containing this asset.